ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1259

Association Between Subclinical Atherosclerosis and Bone Mineral Density in Rheumatoid Arthritis

Barry J. Sheane1, Ruth Dunne2, Ken Scott3, Mary Hall4, Michelle O'Connor2, Martin Healy5, John Feely4, J.B. Walsh6 and Gaye Cunnane7, 1Rheumatology, St. James Hospital, Dublin, Ireland, 2Diagnostic Imaging Department, St James's Hospital, Dublin 8, Ireland, 3Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin 8, Ireland, 4Department of Pharmacology and Therapeutics, St James's Hospital, Dublin 8, Ireland, 5Central Pathology Laboratory, Dublin 8, Ireland, 6Medicine for the Elderly, Dublin 8, Ireland, 7Dept of Rheumatology, St James's Hospital, Dublin, Ireland

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Atherosclerosis, Osteoporosis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Rheumatoid arthritis (RA) is associated with a higher risk of osteoporosis (OP) and cardiovascular disease (CVD). This cross-sectional study was undertaken to identify links between the sub-clinical evidence of these processes.

Methods:

RA patients without known cardiovascular disease or diabetes were included. Measures of osteoporosis risk (DXA, bone turnover markers) and sub-clinical atherosclerosis (pulse wave analysis, carotid intimal-medial thickness (CIMT)) were recorded in addition to serum markers of systemic inflammation and lipid profiles. Data were analysed using SPSS 16.0 for Windows.

Results:

Seventy four RA patients and 26 controls were included in the analysis. Gender and age were similar between RA and controls and between sub-groups of RA duration. The RA group had significantly higher oxidized LDL titres (p<0.001), interleukin-6 (p<0.001), heat shock protein (HSP) 60 (p=0.008), and soluble ICAM-1 (p=0.016) compared with controls. HDL levels were significantly lower in those with RA for <10 years (p=0.026), while LDL (p = 0.014) and HSP60 levels (p = 0.024) were higher. Levels of vitamin D (p = 0.008), TNFα (0.016) and P1NP, a marker of bone formation (p = 0.03), were  higher in those with long-standing RA.

In RA, femur T-scores were inversely related to mean CIMT (cc -0.3, p=0.02), mean common carotid artery IMT (cc -0.3, p=0.02), aortic augmentation index (AAIx) (cc -0.3, p=0.01), CRP (cc -0.4, p=0.002), oxLDL (cc -0.3, p=0.01) and anti-CCP antibody titre (cc -0.25, p=0.046).  T-scores for the spine were also negatively correlated with AAIx (cc -0.4, p<0.001), anti-CCP antibody (cc -0.3, p=0.03), and oxLDL (cc -0.25, p=0.04). For those with osteoporosis, oxLDL was significantly higher compared to those with normal bone density (p=0.016). However, femur T-scores correlated positively with BMI (cc 0.5, p<0.001), waist (cc 0.4, p=0.002) and hip (cc 0.6, p<0.001) circumference, total fat mass (cc 0.4, p=0.01) and trunk fat mass (cc 0.4, p=0.02). T-scores for the spine also correlated with BMI (cc 0.3, p=0.008), waist (cc 0.4, p=0.002) and hip (cc 0.3, p=0.03) circumference.

Conclusion:

Disease duration in RA correlated significantly with risk factors for atherosclerosis, independent of age. Furthermore, reduced bone mineral density was associated with evidence of sub-clinical atherosclerosis. These results suggest that early recognition of such complications may help to improve quality of life and longevity in patients with RA.


Disclosure:

B. J. Sheane,
None;

R. Dunne,
None;

K. Scott,
None;

M. Hall,
None;

M. O’Connor,
None;

M. Healy,
None;

J. Feely,
None;

J. B. Walsh,
None;

G. Cunnane,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-subclinical-atherosclerosis-and-bone-mineral-density-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology